Galectin-3 (Gal-3) plays a multifaceted role in the development, progression, and prognosis
of pancreatic ductal adenocarcinoma (PDAC). This review offers a comprehensive …

Background Galectins constitute a family of β-galactoside-binding proteins, which influence
various hallmarks of pancreatic cancer, including cell proliferation, invasion and migration; …

Simple Summary Galectins are a family of β-galactoside binding proteins whose levels are
altered in various stages of different types of cancer. This study provides an analytical …

Background Galectin-3 as a β-galactoside-binding protein, has been found to be involved in
tumor cell growth, anti-apoptosis, adhesion, angiogenesis, invasion, and distant metastases …

Pancreatic ductal adenocarcinoma (PDAC) is a poor prognosis cancer with an aggressive
growth profile that is often diagnosed at late stage and that has few curative or therapeutic …

Pancreatic cancer is a malignant tumor of the digestive tract, rendering it difficult to make an
accurate diagnosis. The 5 year survival rate for pancreatic cancer is< 1%, and surgical …

Objective The predictive importance of galectin-3 in non-small cell lung cancer (NSCLC) has
not been elucidated. We examined whether galectin-3 could serve as a predictor for tumor …

Galectin-3 reportedly participates in the inflammatory process that causes insulin resistance
in the target tissues. However, the role of high plasma galectin-3 levels as an indicator of …

Galectin-3 (Gal-3) is a new independent risk factor in the development and severity of
coronary artery disease (CAD). The aim of the study was to evaluate whether Gal-3 …

Early detection of pancreatic cancer is crucial for improving patient outcomes, and
identifying reliable biomarkers is a critical research area in this field. Galectin-3 (Gal-3) is a …